English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

HSR Waiting Period Expires for DuPont-FMC Transactionsqrcode

−− Companies Continue to Expect Transactions to Close in Fourth Quarter of 2017

Jun. 15, 2017

Favorites Print
Forward
Jun. 15, 2017

DuPont Crop Protection
United States  United States
Follow

FMC Corporation
United States  United States
Follow

DuPont (NYSE: DD) recently announced that the waiting periods for the approval of its transactions with FMC Corporation ("FMC") under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 have expired without a request for additional information and documentary material by the U.S. Department of Justice.

The expiration of the last of the two waiting periods occurred at 11:59 p.m. EST on June 9. The expirations satisfy certain conditions to the closing of the proposed transactions with FMC, which include FMC acquiring a portion of DuPont Crop Protection business, including certain research and development capabilities, and DuPont acquiring substantially all of FMC's Health & Nutrition business.

DuPont continues to expect the FMC transactions to close in the fourth quarter of 2017, subject to the closing of the DuPont and Dow merger, in addition to other customary closing conditions, including regulatory approvals.

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox